Straumann Holding AG

QS51

Company Profile

  • Business description

    Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

  • Contact

    Peter Merian-Weg 12
    Basel4002
    CHE

    T: +41 619651111

    E: investor.relations@straumann.com

    https://www.straumann-group.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    11,815

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,650.6019.100.22%
CAC 407,826.791.34-0.02%
DAX 4024,226.49198.840.83%
Dow JONES (US)42,343.65740.581.78%
FTSE 1008,778.0560.080.69%
HKSE23,330.1951.80-0.22%
NASDAQ19,199.16461.962.47%
Nikkei 22537,918.86194.750.52%
NZX 50 Index12,357.42224.91-1.79%
S&P 5005,921.54118.722.05%
S&P/ASX 2008,420.7013.100.16%
SSE Composite Index3,342.892.200.07%

Market Movers